Monday, June 17, 2019
facebook
FLASH
  • Militants target army vehicle with IED blast in Pulwama-IANS
Business

Posted at: May 14, 2019, 10:49 AM; last updated: May 14, 2019, 10:49 AM (IST)

Glenmark Pharma gets USFDA nod for acid reflux medication

Glenmark Pharma gets USFDA nod for acid reflux medication
The approved product is a generic version of AstraZeneca Pharmaceuticals’ Nexium delayed-release capsules. iStock

New Delhi, May 14

Glenmark Pharmaceuticals on Tuesday said it had received final approval from the US health regulator for generic version of AstraZeneca’s Nexium, used to treat acid reflux.

Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for Esomeprazole Magnesium delayed-release capsules USP in the strengths of 20 mg and 40 mg, the company said in a BSE filing.

The approved product is a generic version of AstraZeneca Pharmaceuticals’ Nexium delayed-release capsules.

Citing IQVIA sales data, Glenmark said, Nexium delayed-release capsules, 20 mg and 40 mg achieved annual sales of around USD 395.1 million in the 12-month period ended March 2019.

The company said its current portfolio consists of 153 products authorised for distribution in the US and 58 ANDA’s pending approval with the USFDA.

Shares of Glenmark Pharma were trading 0.46 per cent higher at Rs 594.35 apiece on BSE. PTI

COMMENTS

All readers are invited to post comments responsibly. Any messages with foul language or inciting hatred will be deleted. Comments with all capital letters will also be deleted. Readers are encouraged to flag the comments they feel are inappropriate.
The views expressed in the Comments section are of the individuals writing the post. The Tribune does not endorse or support the views in these posts in any manner.
Share On